Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss

Articles From: 2013/3/26 - Orders for big-ticket U.S. goods jump 5.7% to 2013/3/26 - Atlantic American Corporation Reports Fourth Quarter and Year End Results for 2012

This site contains about 63,386 documents.
View by:
Title  |  Date  |  Author  |  Collection  |  Interest  |  Popularity
Page:   1   100   200   300   400   500   630   640   650   660   670   680   690   700   710   718   719   720   721   722   723   724   725   726   727   728   729   730   731   732   733   734   735   736   737   738   739   740   741   742   743   744   745   746   747   750   760   770   780   790   800   810   820   830   900   1,000   1,100   1,200   1,300   1,400   1,500   1,600   1,700   2,000   2,113 

2013/3/26
2013/3/26 - Orders for big-ticket U.S. goods jump 5.7%
WASHINGTON (MarketWatch) — Orders for long-lasting U.S. goods surged in February largely because of gains in the volatile aircraft and defense segments, but demand was mixed for other manufacturers.
View more 2013/3/26 - Orders for big-ticket U.S. goods jump 5.7% analysis
Sign-up for 2013/3/26 - Orders for big-ticket U.S. goods jump 5.7% investment picks
2013/3/26
2013/3/26 - TELUS intends to redeem 2014 Notes early
TELUS intends to redeem 2014 Notes early Canada NewsWire C$700 million 4.95 per cent Notes due May 15, 2014 being redeemed a year early VANCOUVER , March 26, 2013 /CNW/ - TELUS announced today its intention to exercise its right to redeem, in whole or in part, its Canadian dollar denominated $700 million 4.95 per cent Notes due May 15, 2014 a year early, on May 15, 2013 (the "Notes", CUSIP No.
View more 2013/3/26 - TELUS intends to redeem 2014 Notes early analysis
Sign-up for 2013/3/26 - TELUS intends to redeem 2014 Notes early investment picks
2013/3/26
2013/3/26 - NetSuite Named to CRN's 2013 5-Star Partner Program Guide - Again
SAN MATEO, Calif.
View more 2013/3/26 - NetSuite Named to CRN's 2013 5-Star Partner Program Guide - Again analysis
Sign-up for 2013/3/26 - NetSuite Named to CRN's 2013 5-Star Partner Program Guide - Again investment picks
2013/3/26
2013/3/26 - Employers Show Increasing Appetite for Technology to Improve Employee Health Engagement
New research released today by Buck Consultants , A Xerox Company (NYSE: XRX) and WorldatWork reveals that employers are committed to using new technologies to promote health engagement and achieve desired employee behavior changes.
View more 2013/3/26 - Employers Show Increasing Appetite for Technology to Improve Employee Health Engagement analysis
Sign-up for 2013/3/26 - Employers Show Increasing Appetite for Technology to Improve Employee Health Engagement investment picks
2013/3/26
2013/3/26 - Protiviti Webinar: Blueprint for IPO Readiness
Planning, Executing and Managing an Initial Public Offering on Agenda for April 3 Webinar MENLO PARK, Calif.
View more 2013/3/26 - Protiviti Webinar: Blueprint for IPO Readiness analysis
Sign-up for 2013/3/26 - Protiviti Webinar: Blueprint for IPO Readiness investment picks
2013/3/26
2013/3/26 - Asure Software Announces 2012 Fourth Quarter Earnings Conference Call Details
AUSTIN, Texas, March 26, 2013 (GLOBE NEWSWIRE) -- Asure Software (Nasdaq:ASUR) , a leading provider of workplace management software, will release the financial results of its 2012 fourth quarter for the period ended December 31, 2012 on Monday, April 1, 2013.
View more 2013/3/26 - Asure Software Announces 2012 Fourth Quarter Earnings Conference Call Details analysis
Sign-up for 2013/3/26 - Asure Software Announces 2012 Fourth Quarter Earnings Conference Call Details investment picks
2013/3/26
2013/3/26 - Gilead Announces Update on Phase 3 Study of Oral Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients
Gilead Sciences, Inc. (Nasdaq: GILD) today provided an update on ION-1, a Phase 3 clinical trial evaluating a once-daily fixed-dose combination of the nucleotide sofosbuvir and the NS5A inhibitor ledipasvir with and without ribavirin (RBV) for 12 or 24 weeks among treatment-naïve genotype 1 patients with hepatitis C virus (HCV) infection (n=800). A planned review by the study's Data and Safety Monitoring Board (DSMB) of safety data from 200 patients in all four arms and of SVR4 rates (sustained virologic response four weeks after completion of therapy) from 100 patients in the two 12-week duration arms concluded that the trial should continue without modification.
View more 2013/3/26 - Gilead Announces Update on Phase 3 Study of Oral Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients analysis
Sign-up for 2013/3/26 - Gilead Announces Update on Phase 3 Study of Oral Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients investment picks
2013/3/26
2013/3/26 - Zep Inc. To Report Second Quarter Fiscal 2013 Earnings, Host Conference Call on April 9, 2013
Zep Inc. (NYSE:ZEP) , a leading consumable packaged goods company, announced today that it will release its second quarter fiscal 2013 financial results at 7:00 a.m. ET on Tuesday, April 9, 2013 and will hold a conference call to discuss the results at 8:30 a.m. ET the same day.
View more 2013/3/26 - Zep Inc. To Report Second Quarter Fiscal 2013 Earnings, Host Conference Call on April 9, 2013 analysis
Sign-up for 2013/3/26 - Zep Inc. To Report Second Quarter Fiscal 2013 Earnings, Host Conference Call on April 9, 2013 investment picks
2013/3/26
2013/3/26 - Microchip Expands PIC24 Lite Microcontroller Portfolio with Advanced Analog Integration and 5V Operation
Microchip Technology Inc. (NASDAQ: MCHP) , a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, today announced a new addition to its 16-bit PIC ® microcontroller (MCU) portfolio with the low cost PIC24F “KM” family.
View more 2013/3/26 - Microchip Expands PIC24 Lite Microcontroller Portfolio with Advanced Analog Integration and 5V Operation analysis
Sign-up for 2013/3/26 - Microchip Expands PIC24 Lite Microcontroller Portfolio with Advanced Analog Integration and 5V Operation investment picks
2013/3/26
2013/3/26 - Dot Hill AssuredSAN 4000 Series Certified 'DataCore Ready' for SANsymphony-V
LONGMONT, Colo., March 26, 2013 (GLOBE NEWSWIRE) -- Dot Hill Systems Corp.
View more 2013/3/26 - Dot Hill AssuredSAN 4000 Series Certified 'DataCore Ready' for SANsymphony-V analysis
Sign-up for 2013/3/26 - Dot Hill AssuredSAN 4000 Series Certified 'DataCore Ready' for SANsymphony-V investment picks
2013/3/26
2013/3/26 - BioDelivery Sciences Expands Product Pipeline with Acquisition of Patented Topical Clonidine Gel for the Treatment of Painful Diabetic Neuropathy
Completed Phase 2 study demonstrated efficacy in a pain condition with significant unmet need Fast Track status granted by FDA Commercial value estimated to be in excess of $300 million in potential annual peak sales RALEIGH, N.C. , March 26, 2013 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today that it has entered into a worldwide licensing agreement with privately held Arcion Therapeutics (Arcion), where BDSI will develop and commercialize topical clonidine gel (formerly ARC4558) for the treatment of painful diabetic neuropathy (PDN) and potentially other indications.
View more 2013/3/26 - BioDelivery Sciences Expands Product Pipeline with Acquisition of Patented Topical Clonidine Gel for the Treatment of Painful Diabetic Neuropathy analysis
Sign-up for 2013/3/26 - BioDelivery Sciences Expands Product Pipeline with Acquisition of Patented Topical Clonidine Gel for the Treatment of Painful Diabetic Neuropathy investment picks
2013/3/26
2013/3/26 - Foster Wheeler Signs Services Agreement with Valero Refinery in the UK
Foster Wheeler AG (Nasdaq: FWLT) announced today that a subsidiary of its Global Engineering and Construction Group has signed an evergreen agreement with Valero Energy Ltd (Valero) for the provision of home office engineering and project support services to Valero’s Pembroke Refinery and other facilities in the UK.
View more 2013/3/26 - Foster Wheeler Signs Services Agreement with Valero Refinery in the UK analysis
Sign-up for 2013/3/26 - Foster Wheeler Signs Services Agreement with Valero Refinery in the UK investment picks
2013/3/26
2013/3/26 - Extreme Networks Announces Commitment to Reference Design for SDN Switch Leveraging OpenFlow to Increase Data Center, Campus Network Efficiency
Company Extends Open Fabric Campus to Cloud Vision for Open networking via Big Switch Networks 'Switch Light' OpenFlow Thin Switching Software Platform SANTA CLARA, Calif.
View more 2013/3/26 - Extreme Networks Announces Commitment to Reference Design for SDN Switch Leveraging OpenFlow to Increase Data Center, Campus Network Efficiency analysis
Sign-up for 2013/3/26 - Extreme Networks Announces Commitment to Reference Design for SDN Switch Leveraging OpenFlow to Increase Data Center, Campus Network Efficiency investment picks
2013/3/26
2013/3/26 - ZIOPHARM Terminates Development of Palifosfamide in Metastatic Soft Tissue Sarcoma
Restructuring to Place Exclusive Strategic Focus on Synthetic Biology Programs NEW YORK, March 26, 2013 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) , a biopharmaceutical company focused on the development and commercialization of new cancer therapies, announced today that its Phase 3 trial of palifosfamide (ZIO-201) for the treatment of metastatic soft tissue sarcoma in the first-line setting (PICASSO 3) did not meet its primary endpoint of progression-free survival (PFS). The study's independent data monitoring committee (IDMC) has recommended that patients be followed for overall survival (OS), the study's secondary endpoint, however the Company does not expect to continue follow up for OS.
View more 2013/3/26 - ZIOPHARM Terminates Development of Palifosfamide in Metastatic Soft Tissue Sarcoma analysis
Sign-up for 2013/3/26 - ZIOPHARM Terminates Development of Palifosfamide in Metastatic Soft Tissue Sarcoma investment picks
2013/3/26
2013/3/26 - Ambow Education Holding Ltd. Announces Withdrawal of Non-Binding Going Private Proposal
BEIJING , March 26, 2013 /PRNewswire/ -- Ambow Education Holding Ltd.
View more 2013/3/26 - Ambow Education Holding Ltd. Announces Withdrawal of Non-Binding Going Private Proposal analysis
Sign-up for 2013/3/26 - Ambow Education Holding Ltd. Announces Withdrawal of Non-Binding Going Private Proposal investment picks
2013/3/26
2013/3/26 - Ontarians take wait-and-see approach to housing, as purchase intentions drop: RBC Poll
Ontarians take wait-and-see approach to housing, as purchase intentions drop: RBC Poll Canada NewsWire Ontario residents expect higher home prices, steady mortgage rates over the next year TORONTO , March 26, 2013 /CNW/ - While a majority of Ontarians (86 per cent) do not expect to buy a home in the next two years, almost as many (83 per cent) feel that a home or condo is a good investment, according to the 20 th Annual RBC Homeownership Poll.
View more 2013/3/26 - Ontarians take wait-and-see approach to housing, as purchase intentions drop: RBC Poll analysis
Sign-up for 2013/3/26 - Ontarians take wait-and-see approach to housing, as purchase intentions drop: RBC Poll investment picks
2013/3/26
2013/3/26 - GOL increases RASK by 10.5% in 4Q12 and Reaffirms its Supply Rationalization Strategy in 2013
SAO PAULO , March 26, 2013 /PRNewswire/ --  GOL Linhas Aereas Inteligentes S.A. (BM&FBOVESPA: GOLL4 e NYSE: GOL), (S&P: B, Fitch: B+, Moody's: B3), the largest low-cost and low-fare airline in Latin America , announces its results for the fourth quarter of 2012 (4Q12). 4Q12 HIGHLIGHTS Revenue per available seat-kilometer (RASK) grew by 10.5% over 4Q11 , owing to the strategy of rationalizing supply adopted in March 2012 .
View more 2013/3/26 - GOL increases RASK by 10.5% in 4Q12 and Reaffirms its Supply Rationalization Strategy in 2013 analysis
Sign-up for 2013/3/26 - GOL increases RASK by 10.5% in 4Q12 and Reaffirms its Supply Rationalization Strategy in 2013 investment picks
2013/3/26
2013/3/26 - Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Navistar International Corporation
Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court for the Northern District of Illinois on behalf of a class (the “Class”) comprising all purchasers of the common stock of Navistar International Corporation (“Navistar” or the “Company”) (NYSE:NAV) between November 3, 2010 and August 1, 2012, inclusive (the “Class Period”). The Complaint alleges that throughout the Class Period the Company issued materially false and misleading statements regarding the Company’s business and financial prospects.
View more 2013/3/26 - Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Navistar International Corporation analysis
Sign-up for 2013/3/26 - Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Navistar International Corporation investment picks
2013/3/26
2013/3/26 - Kayne Anderson MLP Investment Company Prices Public Offering of Series F Mandatory Redeemable Preferred Shares
Kayne Anderson MLP Investment Company (the “Company”) (NYSE: KYN) announced the pricing of a public offering of preferred stock.
View more 2013/3/26 - Kayne Anderson MLP Investment Company Prices Public Offering of Series F Mandatory Redeemable Preferred Shares analysis
Sign-up for 2013/3/26 - Kayne Anderson MLP Investment Company Prices Public Offering of Series F Mandatory Redeemable Preferred Shares investment picks
2013/3/26
2013/3/26 - The Securities Arbitration Law Firm of Klayman & Toskes Commences Investigation into the Sale of REITs to Ameriprise Financial Customers
The Securities Arbitration Law Firm of Klayman & Toskes (“K&T”), www.reitfraudloss.com , announced today that it is commencing an investigation into the sale of real estate investment trust (“REITs”) products by Ameriprise Financial (NYSE:AMP) to its customers.
View more 2013/3/26 - The Securities Arbitration Law Firm of Klayman & Toskes Commences Investigation into the Sale of REITs to Ameriprise Financial Customers analysis
Sign-up for 2013/3/26 - The Securities Arbitration Law Firm of Klayman & Toskes Commences Investigation into the Sale of REITs to Ameriprise Financial Customers investment picks
2013/3/26
2013/3/26 - Embraer S.A. files Form 20-F report for the fiscal year ended 2012
Notice to the Market SAO JOSE DOS CAMPOS, Brazil , March 26, 2013 /PRNewswire/ -- Embraer S.A. (BOVESPA: EMBR3; NYSE: ERJ) announces that it has filed with the U.S. Securities and Exchange Commission (SEC) its Form 20-F report for the fiscal year ended 2012.
View more 2013/3/26 - Embraer S.A. files Form 20-F report for the fiscal year ended 2012 analysis
Sign-up for 2013/3/26 - Embraer S.A. files Form 20-F report for the fiscal year ended 2012 investment picks
2013/3/26
2013/3/26 - 01 Communique Announces a Decision in its Patent Litigation against LogMeIn
01 Communique Announces a Decision in its Patent Litigation against LogMeIn Canada NewsWire TORONTO , March 26, 2013 /CNW/ - 01 Communique (TSX:ONE) today received a decision in its patent litigation against LogMeIn Inc. The Jury rendered its verdict concluding that LogMeIn does not infringe 01 Communique's patent.
View more 2013/3/26 - 01 Communique Announces a Decision in its Patent Litigation against LogMeIn analysis
Sign-up for 2013/3/26 - 01 Communique Announces a Decision in its Patent Litigation against LogMeIn investment picks
2013/3/26
2013/3/26 - Ameriana Bancorp Names Haywood Director
Ameriana Bancorp (NASDAQ: ASBI) , parent company of Ameriana Bank, today announced that, pursuant to an agreement with PL Capital LLC, Richard J.
View more 2013/3/26 - Ameriana Bancorp Names Haywood Director analysis
Sign-up for 2013/3/26 - Ameriana Bancorp Names Haywood Director investment picks
2013/3/26
2013/3/26 - Cascade Microtech Named Finalist in Oregon Technology Awards
http://media.marketwire.com/attachments/201005/596355_LogoHorzLG.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1001012&ProfileId=051205&sourceType=1 BEAVERTON, OR --
View more 2013/3/26 - Cascade Microtech Named Finalist in Oregon Technology Awards analysis
Sign-up for 2013/3/26 - Cascade Microtech Named Finalist in Oregon Technology Awards investment picks
2013/3/26
2013/3/26 - RenaissanceRe Schedules First Quarter 2013 Financial Results Conference Call
RenaissanceRe Holdings Ltd.
View more 2013/3/26 - RenaissanceRe Schedules First Quarter 2013 Financial Results Conference Call analysis
Sign-up for 2013/3/26 - RenaissanceRe Schedules First Quarter 2013 Financial Results Conference Call investment picks
2013/3/26
2013/3/26 - Quantum Joins Active Archive Alliance
http://media.marketwire.com/attachments/201103/50690_QuantumLogo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1000988&ProfileId=051205&sourceType=1 SAN JOSE, CA --
View more 2013/3/26 - Quantum Joins Active Archive Alliance analysis
Sign-up for 2013/3/26 - Quantum Joins Active Archive Alliance investment picks
2013/3/26
2013/3/26 - Boston Properties and Hines Close on Record Land Sale for Transbay Transit Tower Parcel
Hines and Boston Properties (NYSE: BXP) announced today that it will ceremonially break ground to celebrate the acquisition of 101 First Street, a land parcel sold by Transbay Joint Powers Authority (TJPA) for approximately $192 million.
View more 2013/3/26 - Boston Properties and Hines Close on Record Land Sale for Transbay Transit Tower Parcel analysis
Sign-up for 2013/3/26 - Boston Properties and Hines Close on Record Land Sale for Transbay Transit Tower Parcel investment picks
2013/3/26
2013/3/26 - Top Asian VARs Join NetSuite Solution Provider Program
Leading VARs Offer NetSuite's Cloud-Based Business Management Suite to Meet Growing Demand for Cloud Solutions in Asia SINGAPORE , March 26, 2013 /PRNewswire/ -- NetSuite Inc. (NYSE: N) , the industry's leading provider of cloud -based financials / ERP software suites, today announced that AFON, Software Alliance Partners, Evilog Consulting, Hitpoint and PT.
View more 2013/3/26 - Top Asian VARs Join NetSuite Solution Provider Program analysis
Sign-up for 2013/3/26 - Top Asian VARs Join NetSuite Solution Provider Program investment picks
2013/3/26
2013/3/26 - Dakota Prairie Refinery Celebrates Start of Construction with Groundbreaking Ceremony
Construction of the Dakota Prairie Refinery began today with a groundbreaking ceremony held by the developers, MDU Resources Group, Inc. (NYSE: MDU) and Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT). Construction of the diesel refinery, on a 318-acre site located west of Dickinson in Stark County, N.D. is expected to take approximately 20 months.
View more 2013/3/26 - Dakota Prairie Refinery Celebrates Start of Construction with Groundbreaking Ceremony analysis
Sign-up for 2013/3/26 - Dakota Prairie Refinery Celebrates Start of Construction with Groundbreaking Ceremony investment picks
2013/3/26
2013/3/26 - Atlantic American Corporation Reports Fourth Quarter and Year End Results for 2012
Full year operating earnings up 10.9% from $3.3 million in 2011 to $3.6 million in 2012 Net income up 34.8% from $3.3 million in 2011 to $4.4 million in 2012 Full year diluted earnings per share up 50% from $0.12 in 2011 to $0.18 in 2012 Book value per share up 10.7% from $4.20 at December 31, 2011 to $4.65 at December 31, 2012 Full year life and health premium revenue up 27.6% from $70.0 million in 2011 to $89.3 million in 2012 ATLANTA, March 26, 2013 (GLOBE NEWSWIRE) -- Atlantic American Corporation (Nasdaq:AAME) today reported its results for the fourth quarter and year ended December 31, 2012.
View more 2013/3/26 - Atlantic American Corporation Reports Fourth Quarter and Year End Results for 2012 analysis
Sign-up for 2013/3/26 - Atlantic American Corporation Reports Fourth Quarter and Year End Results for 2012 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
Articles From: 2013/3/26 - Orders for big-ticket U.S. goods jump 5.7% to 2013/3/26 - Atlantic American Corporation Reports Fourth Quarter and Year End Results for 2012
Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Mutual Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title
ETFs by:
Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name
Investment Categories by:
Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry
Premimum Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Premimum Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title
Premimum ETFs by:
Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name
Popular Articles by:
Title |  Date |  Author |  Collection |  Popularity |  Interest
SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Popular SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.